Guidelines for clinical diagnosis and treatment of rejection in kidney transplant recipients in China
10.12464/j.issn.1674-7445.2025019
- VernacularTitle:中国肾脏移植受者排斥反应临床诊疗指南
- Author:
1
;
1
;
1
;
2
;
2
Author Information
1. .
2. Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Collective Name:Branch of organ transplantation of chinese medical association;Branch of organ transplantation physician of chinese medical doctor association
- Publication Type:GuidelineandConsensus
- Keywords:
Kidney transplantation;
Hyperacute rejection;
Acute rejection;
Chronic rejection;
T cell-mediated rejection;
Antibody-mediated rejection;
Donor specific antibody;
Desensitization;
Infection
- From:
Organ Transplantation
2025;16(1):1-20
- CountryChina
- Language:Chinese
-
Abstract:
Rejection in kidney transplantation are significant barriers affecting the survival of recipients and transplant kidneys. To further standardize the clinical diagnosis and treatment of rejection in kidney transplant recipients in China, the Branch of Organ Transplantation of Chinese Medical Association and Branch of Organ Transplantation Physician of Chinese Medical Doctor Association organized kidney transplant experts, transplant immunologists and other experts. Based on the " Technical specification for clinical diagnosis and treatment of renal transplant rejection (2019 edition)" issued by Branch of Organ Transplantation of Chinese Medical Association, and referring to recent domestic and international research findings, expert consensus, guidelines, and mature clinical experience, combined with the current clinical situation of rejection diagnosis and treatment in kidney transplant recipients in China, the "Guidelines for clinical diagnosis and treatment of rejection in kidney transplant recipients in China" have been formulated. The content covers the clinical standard diagnosis and treatment of kidney transplant hyperacute rejection, acute rejection (acute T cell-mediated rejection, acute antibody-mediated rejection), and chronic rejection (chronic active T cell-mediated rejection, chronic active antibody-mediated rejection), aiming to provide theoretical and clinical practice references for the clinical diagnosis and treatment of rejection in Chinese kidney transplant recipients, with the goal of improving and promoting the quality of kidney transplantation.
